BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17277020)

  • 21. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.
    Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF
    Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?
    Mensah K; Mocanu MM; Yellon DM
    J Am Coll Cardiol; 2005 Apr; 45(8):1287-91. PubMed ID: 15837263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.
    Kocsis GF; Pipis J; Fekete V; Kovács-Simon A; Odendaal L; Molnár E; Giricz Z; Janáky T; van Rooyen J; Csont T; Ferdinandy P
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2406-9. PubMed ID: 18359895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels.
    Tavackoli S; Ashitkov T; Hu ZY; Motamedi M; Uretsky BF; Birnbaum Y
    Coron Artery Dis; 2004 Feb; 15(1):53-8. PubMed ID: 15201621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in infarct size by ischemic preconditioning persists in a chronic rat model of myocardial ischemia-reperfusion injury.
    Lott FD; Guo P; Toombs CF
    Pharmacology; 1996 Feb; 52(2):113-8. PubMed ID: 8851632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size.
    Ye Y; Keyes KT; Zhang CF; Perez-Polo JR; Lin Y; Birnbaum Y
    Cardiovasc Drugs Ther; 2010 Apr; 24(2):107-20. PubMed ID: 20379769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins enhance rotator cuff healing by stimulating the COX2/PGE2/EP4 pathway: an in vivo and in vitro study.
    Dolkart O; Liron T; Chechik O; Somjen D; Brosh T; Maman E; Gabet Y
    Am J Sports Med; 2014 Dec; 42(12):2869-76. PubMed ID: 25184246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin Blocks the Infarct-Size Limiting Effect of Ischemic Postconditioning in the Rat.
    Birnbaum Y; Ye R; Ye Y
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):221-224. PubMed ID: 34403016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wake up and smell the coffee: yet another no go for cardiac patients? : editorial to "caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat" by Ye et al.
    Riksen NP; Hausenloy DJ; Yellon DM
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):257-9. PubMed ID: 18415673
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes.
    Schwartz GG; Ganz P; Waters D; Arikian S
    Am J Cardiol; 2003 Nov; 92(9):1109-12. PubMed ID: 14583367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
    Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta.
    Lunder M; Ziberna L; Janić M; Jerin A; Skitek M; Sabovič M; Drevenšek G
    Heart Vessels; 2013 Mar; 28(2):246-54. PubMed ID: 22610592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury.
    Bi XY; He X; Zhao M; Yu XJ; Zang WJ
    J Cardiovasc Pharmacol; 2013 May; 61(5):391-400. PubMed ID: 23364605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation cardioprotective effects of atorvastatin in rats by real time myocardial contrast echocardiography.
    Filusch A; Buss S; Hardt S; Katus HA; Kuecherer HF; Hansen A
    Echocardiography; 2008 Oct; 25(9):974-81. PubMed ID: 18771549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice.
    Ye Y; Lin Y; Manickavasagam S; Perez-Polo JR; Tieu BC; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2436-46. PubMed ID: 18931027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2.
    Tanaka K; Ludwig LM; Krolikowski JG; Alcindor D; Pratt PF; Kersten JR; Pagel PS; Warltier DC
    Anesthesiology; 2004 Mar; 100(3):525-31. PubMed ID: 15108964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats.
    Goes P; Melo IM; Silva LM; Benevides NM; Alencar NM; Ribeiro RA; Lima V
    J Periodontal Res; 2014 Feb; 49(1):45-54. PubMed ID: 23742139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardioprotective effects of atorvastatin preconditioning via iNOS upregulation in a rabbit ischemia/reperfusion model].
    Zhou Y; Chen MH; Liu JH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):1041-5. PubMed ID: 18269828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
    Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.